Might Oral Human Papillomavirus (HPV) Infection in Healthy Individuals Explain Differences in HPV-Attributable Fractions in Oropharyngeal Cancer? A Systematic Review and Meta-analysis
Open Access
- 22 December 2018
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 219 (10) , 1574-1585
Abstract
Differences in oral human papillomavirus (HPV) prevalence and contrasts in HPV-attributable fractions (AFs) in oropharyngeal cancer (OPC) have not been evaluated in depth. A systematic review was performed to identify studies in which at least 50 healthy individuals were tested for oral HPV infection. Information on sex, age, tobacco/alcohol consumption, sex practices, specimen collection, HPV detection, and population type was extracted. Prevalences were pooled using random-effects models for meta-analyses of binomial data. Correlations were assessed by the Spearman test. Forty-eight reports comprising 28 544 individuals fulfilled inclusion criteria. Global oral HPV prevalence was 4.9%. Estimates were highest in Europe, although regional differences were not statistically significant. HPV16 prevalence was 1.0% globally, and regional differences became statistically significant. A lifetime history of >6 sex partners showed a higher risk of oral HPV infection. The age-specific HPV distribution revealed a prevalence of ≥5% over 40 years of age and a lower prevalence at younger ages. There was no association between oral HPV prevalence and HPV-AFs or age-standardized rates (ASRs) of OPC, genital HPV in healthy women, or tobacco use. Differences in HPV-AFs or ASRs of OPC cannot be explained by differences in the prevalence of oral HPV infection across healthy populations. Consistent research on determinants of oral HPV prevalence, acquisition, clearance, and persistence is warranted.Keywords
Funding Information
- Instituto de Salud Carlos III-ISCIII
- European Regional Development Fund–A Way to Build Europe
- Agència de Gestió d’Ajuts Universitaris i de Recerca (2014SGR756, 2014SGR1077, 2017SGR1085, 2017SGR1718)
- Department of Health of the Generalitat de Catalunya (PERIS-2016–2020, SLT002/16/00404)
- 7th Framework Programme of the European Commission (COHEARH FP7-Health-F3-2013–603019, HPV-AHEAD FP7-HEALTH-2011–282562, PIE16/00049)
This publication has 48 references indexed in Scilit:
- Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort studyThe Lancet, 2013
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- Oral Human Papillomavirus in Healthy Individuals: A Systematic Review of the LiteratureSexually Transmitted Diseases, 2010
- Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targetsVaccine, 2010
- Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortiumInternational Journal of Epidemiology, 2009
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementJournal of Clinical Epidemiology, 2009
- New saliva DNA collection method compared to buccal cell collection techniques for epidemiological studiesAmerican Journal of Human Biology, 2007
- Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancerInternational Journal of Cancer, 2006
- Analysis of the Effect of DNA Purification on Detection of Human Papillomavirus in Oral Rinse Samples by PCRJournal of Clinical Microbiology, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003